releases: https://pappas.house.gov/media/press-releases/house-passes-bipartisan-bill-to-address-overdose-crisis-including-pappas-provision-to-crack-down-on-deadly-xylazine
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://pappas.house.gov/media/press-releases/house-passes-bipartisan-bill-to-address-overdose-crisis-including-pappas-provision-to-crack-down-on-deadly-xylazine | House Passes Bipartisan Bill to Address Overdose Crisis, Including Pappas Provision to Crack Down on Deadly Xylazine | 2023-12-12 | 2023 | 2023-12 | Democrat | House | NH | Chris Pappas | P000614 | pappas.house.gov | pappas | https://pappas.house.gov/media/press-releases | scraper | Today Congressman Chris Pappas (NH-01), a member of the Bipartisan Mental Health and Substance Use Disorder Task Force, helped pass the bipartisan Support for Patients and Communities Reauthorization (SUPPORT) Act in the House. This bill includes Pappas’s provision to classify xylazine as a schedule III controlled substance from his bipartisan Combating Illicit Xylazine Act. The SUPPORT Act, which was led by Rep. Annie Kuster (NH-02), will help communities better address the overdose crisis by expanding access to substance use disorder treatment, support first responders and mental health workers, and more. The Combating Illicit Xylazine Act will crack down on the manufacture and sale of xylazine, which can be legally used as an animal tranquilizer, by listing it as a controlled substance and better coordinating federal agencies to ensure law enforcement has the resources needed to crack down on illegal drug traffickers. Pappas introduced this bill earlier this year. | 1 | 2026-03-30T01:40:41Z | 2026-04-08T01:14:16Z |